Trial Profile
Special Investigation (All Cases Investigation in Patients With Psoriasis Vulgaris and Psoriatic Arthritis)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Nov 2021
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Plaque psoriasis; Psoriatic arthritis
- Focus Adverse reactions; Therapeutic Use
- Acronyms SALSA
- Sponsors Abbott Laboratories; AbbVie
- 25 Mar 2014 Results presented at the 72nd Annual Meeting of the American Academy of Dermatology.
- 14 Sep 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 13 Aug 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.